Eggermont AM - Search Results

1

Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes.

van Akkooi AC, Nowecki ZI, Voit C, Schäfer-Hesterberg G, Michej W, de Wilt JH, Rutkowski P, Verhoef C, Eggermont AM. van Akkooi AC, et al. Among authors: eggermont am. Ann Surg. 2008 Dec;248(6):949-55. doi: 10.1097/SLA.0b013e31818fefe0. Ann Surg. 2008. PMID: 19092339

2

Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan.

Klaase JM, Kroon BB, van Geel AN, Eggermont AM, Franklin HR, Hart AA. Klaase JM, et al. Among authors: eggermont am. Surgery. 1994 Jan;115(1):39-45. Surgery. 1994. PMID: 8284759

3

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience.

Eggermont AM, Schraffordt Koops H, Klausner JM, Kroon BB, Schlag PM, Liénard D, van Geel AN, Hoekstra HJ, Meller I, Nieweg OE, Kettelhack C, Ben-Ari G, Pector JC, Lejeune FJ. Eggermont AM, et al. Ann Surg. 1996 Dec;224(6):756-64; discussion 764-5. doi: 10.1097/00000658-199612000-00011. Ann Surg. 1996. PMID: 8968230 Free PMC article. Clinical Trial.

4

Tumor necrosis factor-alpha in isolated perfusion systems in the treatment of cancer: the Rotterdam preclinical-clinical program.

Manusama ER, Nooijen PT, Ten Hagen TL, Van Der Veen AH, De Vries MW, De Wilt JH, Van Ijken MG, Marquet RL, Eggermont AM. Manusama ER, et al. Among authors: eggermont am. Semin Surg Oncol. 1998 Apr-May;14(3):232-7. doi: 10.1002/(sici)1098-2388(199804/05)14:3<232::aid-ssu7>3.0.co;2-9. Semin Surg Oncol. 1998. PMID: 9548606

5

Assessment of the role of neutrophils on the antitumor effect of TNFalpha in an in vivo isolated limb perfusion model in sarcoma-bearing brown Norway rats.

Manusama ER, Nooijen PT, Stavast J, de Wilt JH, Marquet RL, Eggermont AM. Manusama ER, et al. Among authors: eggermont am. J Surg Res. 1998 Aug;78(2):169-75. doi: 10.1006/jsre.1997.5256. J Surg Res. 1998. PMID: 9733636

6

Isolated hypoxic hepatic perfusion with tumor necrosis factor-alpha, melphalan, and mitomycin C using balloon catheter techniques: a pharmacokinetic study in pigs.

van Ijken MG, de Bruijn EA, de Boeck G, ten Hagen TL, van der Sijp JR, Eggermont AM. van Ijken MG, et al. Among authors: eggermont am. Ann Surg. 1998 Dec;228(6):763-70. doi: 10.1097/00000658-199812000-00007. Ann Surg. 1998. PMID: 9860475 Free PMC article.

7

Toxicity and antitumor activity of interferon gamma alone and in combinations with TNFalpha and melphalan in isolated limb perfusion in the BN175 sarcoma tumor model in rats.

Manusama ER, De Wilt JH, Ten Hagen TL, Marquet RL, Eggermont AM. Manusama ER, et al. Among authors: eggermont am. Oncol Rep. 1999 Jan-Feb;6(1):173-7. doi: 10.3892/or.6.1.173. Oncol Rep. 1999. PMID: 9864423

8

Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats.

de Wilt JH, Manusama ER, van Tiel ST, van Ijken MG, ten Hagen TL, Eggermont AM. de Wilt JH, et al. Among authors: eggermont am. Br J Cancer. 1999 Apr;80(1-2):161-6. doi: 10.1038/sj.bjc.6690335. Br J Cancer. 1999. PMID: 10389992 Free PMC article.

9

Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer.

de Kanter AY, van Eijck CH, van Geel AN, Kruijt RH, Henzen SC, Paul MA, Eggermont AM, Wiggers T. de Kanter AY, et al. Among authors: eggermont am. Br J Surg. 1999 Nov;86(11):1459-62. doi: 10.1046/j.1365-2168.1999.01243.x. Br J Surg. 1999. PMID: 10583296

10

TNF-alpha augments intratumoural concentrations of doxorubicin in TNF-alpha-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects.

van der Veen AH, de Wilt JH, Eggermont AM, van Tiel ST, Seynhaeve AL, ten Hagen TL. van der Veen AH, et al. Among authors: eggermont am. Br J Cancer. 2000 Feb;82(4):973-80. doi: 10.1054/bjoc.1999.1027. Br J Cancer. 2000. PMID: 10732774 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

654 results

Search Page